Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy
Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 199...
Saved in:
Published in | Journal of clinical neurology (Seoul, Korea) Vol. 16; no. 4; pp. 547 - 555 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Korean Neurological Association
01.10.2020
대한신경과학회 |
Subjects | |
Online Access | Get full text |
ISSN | 1738-6586 2005-5013 |
DOI | 10.3988/jcn.2020.16.4.547 |
Cover
Loading…
Abstract | Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures. |
---|---|
AbstractList | Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures. Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures. KCI Citation Count: 0 Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures.Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin, primidone, and ethosuximide were developed in the early 20th century. More than 10 types of antiepileptic drugs have been developed since the 1990s, and there are now more than 20 antiepileptic drugs in active clinical use. The choice of antiepileptic drugs is based on the clinical features of the seizure types, electroencephalogram findings, epileptic syndrome, and drug stability. Currently there are 19 antiepileptic drugs approved by the Korean Food and Drug Administration, 18 of which (with the exclusion of brivaracetam) are covered by the National Health Insurance Service in Korea. We reviewed the selection of antiepileptic drugs according to the classification of epileptic seizures. |
Author | Lee, Soon-Tae Seo, Jong-Geun Kim, Keun Tae Yang, Kwang Ik Kim, Hyeyun Kang, Kyung Wook Kim, Daeyoung Byun, Jung-Ick No, Young Joo Kim, Dong Wook Cho, Yong Won |
AuthorAffiliation | e Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea g Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea i Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea c Department of Neurology, Seoul National University Hospital, Seoul, Korea f Department of Neurology, Samsung Noble County, Yongin, Korea h Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea a Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea b Department of Neurology, Konkuk University School of Medicine, Seoul, Korea d Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea j Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea |
AuthorAffiliation_xml | – name: b Department of Neurology, Konkuk University School of Medicine, Seoul, Korea – name: e Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea – name: d Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea – name: a Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea – name: i Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea – name: g Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea – name: f Department of Neurology, Samsung Noble County, Yongin, Korea – name: c Department of Neurology, Seoul National University Hospital, Seoul, Korea – name: h Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea – name: j Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea |
Author_xml | – sequence: 1 givenname: Hyeyun orcidid: 0000-0002-8008-5539 surname: Kim fullname: Kim, Hyeyun organization: Department of Neurology, Catholic Kwandong University College of Medicine, International St. Mary's Hospital, Incheon, Korea – sequence: 2 givenname: Dong Wook orcidid: 0000-0003-4484-0602 surname: Kim fullname: Kim, Dong Wook organization: Department of Neurology, Konkuk University School of Medicine, Seoul, Korea – sequence: 3 givenname: Soon-Tae orcidid: 0000-0003-4767-7564 surname: Lee fullname: Lee, Soon-Tae organization: Department of Neurology, Seoul National University Hospital, Seoul, Korea – sequence: 4 givenname: Jung-Ick orcidid: 0000-0002-6224-4575 surname: Byun fullname: Byun, Jung-Ick organization: Department of Neurology, Kyunghee University Hospital at Gangdong, Seoul, Korea – sequence: 5 givenname: Jong-Geun orcidid: 0000-0002-3944-5731 surname: Seo fullname: Seo, Jong-Geun organization: Department of Neurology, School of Medicine, Kyungpook National University, Daegu, Korea – sequence: 6 givenname: Young Joo orcidid: 0000-0002-0145-5707 surname: No fullname: No, Young Joo organization: Department of Neurology, Samsung Noble County, Yongin, Korea – sequence: 7 givenname: Kyung Wook orcidid: 0000-0001-9362-8670 surname: Kang fullname: Kang, Kyung Wook organization: Department of Neurology, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Korea – sequence: 8 givenname: Daeyoung orcidid: 0000-0001-9056-0017 surname: Kim fullname: Kim, Daeyoung organization: Department of Neurology, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea – sequence: 9 givenname: Keun Tae orcidid: 0000-0002-7124-0736 surname: Kim fullname: Kim, Keun Tae organization: Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea – sequence: 10 givenname: Yong Won orcidid: 0000-0002-6127-1045 surname: Cho fullname: Cho, Yong Won organization: Department of Neurology, Keimyung University, School of Medicine, Daegu, Korea – sequence: 11 givenname: Kwang Ik orcidid: 0000-0001-6343-6520 surname: Yang fullname: Yang, Kwang Ik organization: Department of Neurology, Soonchunhyang University College of Medicine, Cheonan Hospital, Cheonan, Korea |
BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002632164$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kc1u1DAURi1URKeFB2CXJSyS-t_xBmnUFlqpEgim3VqO40zdZuxgO6Dh6fHMVJXKgtWVfL9zfKXvBBz54C0A7xFsiGzbswfjGwwxbBBvaMOoeAUWGEJWM4jIEVggQdqas5Yfg5OUHiDkArboDTgmBGIpmVyAu6XPzk5utFN2prqI87r6YUdrsgu-WhoTYu_8usqhPLs_c7TVajvZypVlP4-5-qYL73Oqfrt8X13uTWn7Frwe9Jjsu6d5Cm4_X67Or-qbr1-uz5c3taEI5hp3tuew7wYthDC47RgiPemZ1Ax1QvaCYQkNQgOnVMNOaAtZp-XAO9pKhgw5BR8PXh8H9WicCtrt5zqox6iW31fXSrIWc45L9tMhO83dxvamXB31qKboNjpu9-TLjXf3xfNLCUaRFKQIPjwJYvg525TVxiVjx1F7G-akMKUSM9oyWqLoEDUxpBTt8PwNgmrXnSrdqV13CnFFVemuMOIfxrisdz2Ua9z4H_IvwoSg6Q |
CitedBy_id | crossref_primary_10_1016_j_snb_2024_136766 crossref_primary_10_1186_s12967_023_04490_z crossref_primary_10_3390_jcm13133983 crossref_primary_10_1177_20420986231181337 crossref_primary_10_1016_j_cardfail_2021_07_020 crossref_primary_10_3390_healthcare12080830 crossref_primary_10_1002_adma_202203667 crossref_primary_10_1016_j_yebeh_2022_108611 crossref_primary_10_20961_plexus_v2i3_566 crossref_primary_10_1016_j_bbe_2022_04_004 crossref_primary_10_1021_acs_analchem_3c05641 crossref_primary_10_1016_j_seizure_2021_03_009 crossref_primary_10_1007_s40263_023_01013_8 crossref_primary_10_1016_j_eplepsyres_2023_107138 crossref_primary_10_2174_0118715273275793231030060833 crossref_primary_10_3390_pharmaceutics15020306 crossref_primary_10_17749_2077_8333_epi_par_con_2024_210 crossref_primary_10_1166_jbt_2022_2968 crossref_primary_10_17340_jkna_2023_1_17 crossref_primary_10_1016_j_survophthal_2025_01_002 crossref_primary_10_1007_s11064_024_04244_3 crossref_primary_10_3390_biomedicines11071955 |
Cites_doi | 10.2165/00003088-200645110-00002 10.1212/WNL.43.11.2292 10.1016/j.jpainsymman.2018.07.012 10.1212/WNL.0b013e3182194bd3 10.1016/j.eplepsyres.2017.10.003 10.1136/archdischild-2012-302822 10.1111/j.1528-1157.1987.tb05766.x 10.2147/NDT.S188111 10.1056/NEJMoa0902014 10.1056/NEJM199712183372504 10.1016/j.seizure.2010.10.027 10.1016/j.eplepsyres.2007.06.002 10.1016/j.seizure.2008.06.009 10.1111/j.0013-9580.2004.06204.x 10.1111/j.1468-1331.2004.00874.x 10.1007/s40265-015-0514-7 10.1136/bmj.286.6373.1246 10.1212/01.wnl.0000297512.18364.40 10.1111/epi.13671 10.3310/hta11370 10.1016/j.yebeh.2016.11.018 10.1007/s40272-019-00325-x 10.1016/j.seizure.2003.06.001 10.1038/jhg.2017.91 10.1016/S0140-6736(07)60461-9 10.1111/j.1499-1654.2000.001597.x 10.1016/j.yebeh.2016.04.002 10.2147/NDT.S185774 10.1016/S1059-1311(95)80003-4 10.1016/S0140-6736(07)60460-7 10.1016/S0887-8994(02)00468-X 10.1016/j.braindev.2016.02.005 10.1016/j.nurt.2006.10.005 10.1016/j.seizure.2018.10.016 10.1007/s40263-016-0344-5 10.1016/j.yebeh.2020.106942 10.1111/epi.13502 10.1016/j.seizure.2013.07.006 10.1016/j.seizure.2007.04.007 10.1111/j.1528-1167.2006.00585.x 10.1053/seiz.2000.0444 10.1212/WNL.55.2.236 10.1046/j.1528-1157.2001.31600.x 10.1016/j.nurt.2006.11.004 10.1212/WNL.0000000000001930 10.1684/epd.2008.0168 10.1111/j.1469-8749.2008.03099.x |
ContentType | Journal Article |
Copyright | Copyright © 2020 Korean Neurological Association. Copyright © 2020 Korean Neurological Association 2020 Korean Neurological Association |
Copyright_xml | – notice: Copyright © 2020 Korean Neurological Association. – notice: Copyright © 2020 Korean Neurological Association 2020 Korean Neurological Association |
CorporateAuthor | on behalf of the Drug Committee of Korean Epilepsy Society |
CorporateAuthor_xml | – name: on behalf of the Drug Committee of Korean Epilepsy Society |
DBID | AAYXX CITATION 7X8 5PM ACYCR |
DOI | 10.3988/jcn.2020.16.4.547 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2005-5013 |
EndPage | 555 |
ExternalDocumentID | oai_kci_go_kr_ARTI_9582662 PMC7541973 10_3988_jcn_2020_16_4_547 |
GroupedDBID | 29K 2WC 5-W 5GY 8JR 8XY 9ZL AAKDD AAYXX ACYCR ADBBV ADRAZ AENEX ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CITATION D-I DIK DU5 E3Z EF. F5P GROUPED_DOAJ HYE KQ8 M48 OK1 PGMZT RPM 7X8 5PM |
ID | FETCH-LOGICAL-c410t-2bed60dbfa777c28b513d3d59a51b79d75290c11f644a0b7ae05ba9f6b48951c3 |
IEDL.DBID | M48 |
ISSN | 1738-6586 |
IngestDate | Sun Mar 09 07:50:40 EDT 2025 Thu Aug 21 14:15:02 EDT 2025 Fri Jul 11 00:54:31 EDT 2025 Thu Apr 24 22:50:31 EDT 2025 Tue Jul 01 03:10:51 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c410t-2bed60dbfa777c28b513d3d59a51b79d75290c11f644a0b7ae05ba9f6b48951c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 https://doi.org/10.3988/jcn.2020.16.4.547 |
ORCID | 0000-0003-4484-0602 0000-0002-8008-5539 0000-0003-4767-7564 0000-0002-6127-1045 0000-0002-6224-4575 0000-0001-9056-0017 0000-0002-3944-5731 0000-0001-6343-6520 0000-0002-7124-0736 0000-0001-9362-8670 0000-0002-0145-5707 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3988/jcn.2020.16.4.547 |
PMID | 33029959 |
PQID | 2449254854 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_9582662 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7541973 proquest_miscellaneous_2449254854 crossref_primary_10_3988_jcn_2020_16_4_547 crossref_citationtrail_10_3988_jcn_2020_16_4_547 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-10-01 |
PublicationDateYYYYMMDD | 2020-10-01 |
PublicationDate_xml | – month: 10 year: 2020 text: 2020-10-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Journal of clinical neurology (Seoul, Korea) |
PublicationYear | 2020 |
Publisher | Korean Neurological Association 대한신경과학회 |
Publisher_xml | – name: Korean Neurological Association – name: 대한신경과학회 |
References | Davies (10.3988/jcn.2020.16.4.547_ref10) 1995; 4 Machado (10.3988/jcn.2020.16.4.547_ref47) 2013; 22 Zhu (10.3988/jcn.2020.16.4.547_ref11) 2017; 62 Vossler (10.3988/jcn.2020.16.4.547_ref48) 2008; 10 French (10.3988/jcn.2020.16.4.547_ref5) 2004; 45 Glauser (10.3988/jcn.2020.16.4.547_ref40) 2010; 362 Brigo (10.3988/jcn.2020.16.4.547_ref41) 2017; 2 French (10.3988/jcn.2020.16.4.547_ref34) 2011; 76 Motte (10.3988/jcn.2020.16.4.547_ref49) 1997; 337 Sun (10.3988/jcn.2020.16.4.547_ref27) 2009; 18 Allen (10.3988/jcn.2020.16.4.547_ref37) 1983; 286 Brodie (10.3988/jcn.2020.16.4.547_ref1) 2010; 19 Chadwick (10.3988/jcn.2020.16.4.547_ref20) 1987; 28 Suppl 2 Marson (10.3988/jcn.2020.16.4.547_ref18) 2007; 11 Verrotti (10.3988/jcn.2020.16.4.547_ref44) 2008; 50 Appleton (10.3988/jcn.2020.16.4.547_ref6) 2012; 97 Krakow (10.3988/jcn.2020.16.4.547_ref29) 2007; 16 Johannessen (10.3988/jcn.2020.16.4.547_ref13) 2006; 45 Vossler (10.3988/jcn.2020.16.4.547_ref30) 2016; 57 Shih (10.3988/jcn.2020.16.4.547_ref31) 2017; 69 Barcs (10.3988/jcn.2020.16.4.547_ref26) 2000; 41 Maiti (10.3988/jcn.2020.16.4.547_ref15) 2017; 138 Fisher (10.3988/jcn.2020.16.4.547_ref14) 2017; 58 Chen (10.3988/jcn.2020.16.4.547_ref21) 2019; 15 Marson (10.3988/jcn.2020.16.4.547_ref16) 2007; 369 Byun (10.3988/jcn.2020.16.4.547_ref17) 2020; 105 Korean Epilepsy Society (10.3988/jcn.2020.16.4.547_ref9) 2015 National Clinical Guideline Centre (10.3988/jcn.2020.16.4.547_ref36) 2012 Fabris (10.3988/jcn.2020.16.4.547_ref4) 2016; 60 Scott (10.3988/jcn.2020.16.4.547_ref2) 2015; 75 Jozwiak (10.3988/jcn.2020.16.4.547_ref24) 2000; 9 The US Gabapentin Study Group No. 5 (10.3988/jcn.2020.16.4.547_ref23) 1993; 43 Dahlin (10.3988/jcn.2020.16.4.547_ref43) 2003; 28 Almeida (10.3988/jcn.2020.16.4.547_ref33) 2007; 4 Glauser (10.3988/jcn.2020.16.4.547_ref8) 2006; 47 Bektaş (10.3988/jcn.2020.16.4.547_ref52) 2016; 38 Scottish Intercollegiate Guidelines Network (10.3988/jcn.2020.16.4.547_ref7) 2011 French (10.3988/jcn.2020.16.4.547_ref39) 2015; 85 Kessler (10.3988/jcn.2020.16.4.547_ref45) 2019; 21 Jedrzejczak (10.3988/jcn.2020.16.4.547_ref28) 2005; 12 Hoy (10.3988/jcn.2020.16.4.547_ref3) 2016; 30 Cereghino (10.3988/jcn.2020.16.4.547_ref19) 2000; 55 von Rosenstiel (10.3988/jcn.2020.16.4.547_ref32) 2007; 4 Kumar (10.3988/jcn.2020.16.4.547_ref38) 2004; 13 Verrotti (10.3988/jcn.2020.16.4.547_ref50) 2018; 63 Marson (10.3988/jcn.2020.16.4.547_ref35) 2007; 369 Howard (10.3988/jcn.2020.16.4.547_ref12) 2018; 56 Montenegro (10.3988/jcn.2020.16.4.547_ref22) 2001; 42 Steinhoff (10.3988/jcn.2020.16.4.547_ref25) 2007; 76 Balagura (10.3988/jcn.2020.16.4.547_ref51) 2020; 16 Noachtar (10.3988/jcn.2020.16.4.547_ref46) 2008; 70 Nevitt (10.3988/jcn.2020.16.4.547_ref42) 2018; 8 |
References_xml | – volume: 45 start-page: 1061 year: 2006 ident: 10.3988/jcn.2020.16.4.547_ref13 publication-title: Clin Pharmacokinet doi: 10.2165/00003088-200645110-00002 – volume: 43 start-page: 2292 year: 1993 ident: 10.3988/jcn.2020.16.4.547_ref23 publication-title: Neurology doi: 10.1212/WNL.43.11.2292 – volume: 56 start-page: 645 year: 2018 ident: 10.3988/jcn.2020.16.4.547_ref12 publication-title: J Pain Symptom Manage doi: 10.1016/j.jpainsymman.2018.07.012 – volume: 76 start-page: 1555 year: 2011 ident: 10.3988/jcn.2020.16.4.547_ref34 publication-title: Neurology doi: 10.1212/WNL.0b013e3182194bd3 – volume: 138 start-page: 5 year: 2017 ident: 10.3988/jcn.2020.16.4.547_ref15 publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2017.10.003 – volume: 97 start-page: 1073 year: 2012 ident: 10.3988/jcn.2020.16.4.547_ref6 publication-title: Arch Dis Child doi: 10.1136/archdischild-2012-302822 – volume: 28 Suppl 2 start-page: S12 year: 1987 ident: 10.3988/jcn.2020.16.4.547_ref20 publication-title: Epilepsia doi: 10.1111/j.1528-1157.1987.tb05766.x – volume: 15 start-page: 905 year: 2019 ident: 10.3988/jcn.2020.16.4.547_ref21 publication-title: Neuropsychiatr Dis Treat doi: 10.2147/NDT.S188111 – volume: 362 start-page: 790 year: 2010 ident: 10.3988/jcn.2020.16.4.547_ref40 publication-title: N Engl J Med doi: 10.1056/NEJMoa0902014 – volume: 337 start-page: 1807 year: 1997 ident: 10.3988/jcn.2020.16.4.547_ref49 publication-title: N Engl J Med doi: 10.1056/NEJM199712183372504 – volume: 19 start-page: 650 year: 2010 ident: 10.3988/jcn.2020.16.4.547_ref1 publication-title: Seizure doi: 10.1016/j.seizure.2010.10.027 – volume: 76 start-page: 6 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref25 publication-title: Epilepsy Res doi: 10.1016/j.eplepsyres.2007.06.002 – volume: 18 start-page: 90 year: 2009 ident: 10.3988/jcn.2020.16.4.547_ref27 publication-title: Seizure doi: 10.1016/j.seizure.2008.06.009 – volume: 45 start-page: 401 year: 2004 ident: 10.3988/jcn.2020.16.4.547_ref5 publication-title: Epilepsia doi: 10.1111/j.0013-9580.2004.06204.x – volume: 12 start-page: 176 year: 2005 ident: 10.3988/jcn.2020.16.4.547_ref28 publication-title: Eur J Neurol doi: 10.1111/j.1468-1331.2004.00874.x – volume: 75 start-page: 2143 year: 2015 ident: 10.3988/jcn.2020.16.4.547_ref2 publication-title: Drugs doi: 10.1007/s40265-015-0514-7 – volume: 286 start-page: 1246 year: 1983 ident: 10.3988/jcn.2020.16.4.547_ref37 publication-title: Br Med J (Clin Res Ed) doi: 10.1136/bmj.286.6373.1246 – volume: 70 start-page: 607 year: 2008 ident: 10.3988/jcn.2020.16.4.547_ref46 publication-title: Neurology doi: 10.1212/01.wnl.0000297512.18364.40 – volume: 58 start-page: 531 year: 2017 ident: 10.3988/jcn.2020.16.4.547_ref14 publication-title: Epilepsia doi: 10.1111/epi.13671 – volume: 11 issue: 37 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref18 publication-title: Health Technol Assess doi: 10.3310/hta11370 – volume: 69 start-page: 186 year: 2017 ident: 10.3988/jcn.2020.16.4.547_ref31 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2016.11.018 – volume: 21 start-page: 15 year: 2019 ident: 10.3988/jcn.2020.16.4.547_ref45 publication-title: Paediatr Drugs doi: 10.1007/s40272-019-00325-x – volume: 13 start-page: 475 year: 2004 ident: 10.3988/jcn.2020.16.4.547_ref38 publication-title: Seizure doi: 10.1016/j.seizure.2003.06.001 – volume: 62 start-page: 1009 year: 2017 ident: 10.3988/jcn.2020.16.4.547_ref11 publication-title: J Hum Genet doi: 10.1038/jhg.2017.91 – volume: 369 start-page: 1016 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref35 publication-title: Lancet doi: 10.1016/S0140-6736(07)60461-9 – volume: 41 start-page: 1597 year: 2000 ident: 10.3988/jcn.2020.16.4.547_ref26 publication-title: Epilepsia doi: 10.1111/j.1499-1654.2000.001597.x – volume-title: Clinical guideline for antiepileptic drug treatment in patient with epilepsy year: 2015 ident: 10.3988/jcn.2020.16.4.547_ref9 – volume: 60 start-page: 17 year: 2016 ident: 10.3988/jcn.2020.16.4.547_ref4 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2016.04.002 – volume: 16 start-page: 369 year: 2020 ident: 10.3988/jcn.2020.16.4.547_ref51 publication-title: Neuropsychiatr Dis Treat doi: 10.2147/NDT.S185774 – volume: 4 start-page: 267 year: 1995 ident: 10.3988/jcn.2020.16.4.547_ref10 publication-title: Seizure doi: 10.1016/S1059-1311(95)80003-4 – volume: 369 start-page: 1000 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref16 publication-title: Lancet doi: 10.1016/S0140-6736(07)60460-7 – volume: 28 start-page: 48 year: 2003 ident: 10.3988/jcn.2020.16.4.547_ref43 publication-title: Pediatr Neurol doi: 10.1016/S0887-8994(02)00468-X – volume: 38 start-page: 654 year: 2016 ident: 10.3988/jcn.2020.16.4.547_ref52 publication-title: Brain Dev doi: 10.1016/j.braindev.2016.02.005 – volume: 2 start-page: CD003032 year: 2017 ident: 10.3988/jcn.2020.16.4.547_ref41 publication-title: Cochrane Database Syst Rev – volume: 4 start-page: 88 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref33 publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2006.10.005 – volume: 63 start-page: 17 year: 2018 ident: 10.3988/jcn.2020.16.4.547_ref50 publication-title: Seizure doi: 10.1016/j.seizure.2018.10.016 – volume: 30 start-page: 559 year: 2016 ident: 10.3988/jcn.2020.16.4.547_ref3 publication-title: CNS Drugs doi: 10.1007/s40263-016-0344-5 – volume: 105 start-page: 106942 year: 2020 ident: 10.3988/jcn.2020.16.4.547_ref17 publication-title: Epilepsy Behav doi: 10.1016/j.yebeh.2020.106942 – volume: 57 start-page: 1625 year: 2016 ident: 10.3988/jcn.2020.16.4.547_ref30 publication-title: Epilepsia doi: 10.1111/epi.13502 – volume: 8 start-page: CD001769 year: 2018 ident: 10.3988/jcn.2020.16.4.547_ref42 publication-title: Cochrane Database Syst Rev – volume: 22 start-page: 846 year: 2013 ident: 10.3988/jcn.2020.16.4.547_ref47 publication-title: Seizure doi: 10.1016/j.seizure.2013.07.006 – volume: 16 start-page: 593 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref29 publication-title: Seizure doi: 10.1016/j.seizure.2007.04.007 – volume: 47 start-page: 1094 year: 2006 ident: 10.3988/jcn.2020.16.4.547_ref8 publication-title: Epilepsia doi: 10.1111/j.1528-1167.2006.00585.x – volume: 9 start-page: 486 year: 2000 ident: 10.3988/jcn.2020.16.4.547_ref24 publication-title: Seizure doi: 10.1053/seiz.2000.0444 – volume-title: The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care year: 2012 ident: 10.3988/jcn.2020.16.4.547_ref36 – volume: 55 start-page: 236 year: 2000 ident: 10.3988/jcn.2020.16.4.547_ref19 publication-title: Neurology doi: 10.1212/WNL.55.2.236 – volume: 42 start-page: 539 year: 2001 ident: 10.3988/jcn.2020.16.4.547_ref22 publication-title: Epilepsia doi: 10.1046/j.1528-1157.2001.31600.x – volume: 4 start-page: 84 year: 2007 ident: 10.3988/jcn.2020.16.4.547_ref32 publication-title: Neurotherapeutics doi: 10.1016/j.nurt.2006.11.004 – volume-title: SIGN 50: a guideline developer's handbook year: 2011 ident: 10.3988/jcn.2020.16.4.547_ref7 – volume: 85 start-page: 950 year: 2015 ident: 10.3988/jcn.2020.16.4.547_ref39 publication-title: Neurology doi: 10.1212/WNL.0000000000001930 – volume: 10 start-page: 31 year: 2008 ident: 10.3988/jcn.2020.16.4.547_ref48 publication-title: Epileptic Disord doi: 10.1684/epd.2008.0168 – volume: 50 start-page: 850 year: 2008 ident: 10.3988/jcn.2020.16.4.547_ref44 publication-title: Dev Med Child Neurol doi: 10.1111/j.1469-8749.2008.03099.x |
SSID | ssj0067081 |
Score | 2.3111496 |
SecondaryResourceType | review_article |
Snippet | Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin,... Epilepsy is a common neurological disorder that is mainly treated using antiepileptic drugs. Several antiepileptic drugs such as phenobarbital, phenytoin,... |
SourceID | nrf pubmedcentral proquest crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 547 |
SubjectTerms | Review 신경과학 |
Title | Antiepileptic Drug Selection According to Seizure Type in Adult Patients with Epilepsy |
URI | https://www.proquest.com/docview/2449254854 https://pubmed.ncbi.nlm.nih.gov/PMC7541973 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002632164 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Clinical Neurology, 2020, 16(4), , pp.547-555 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9wwEBY5oPSlNGlLNxdq6FPBi2zrsB5CCTlIA1sK7Za8CUmWEyfBm3q9kPTXd8b2LjWE0ieDD1nMaDzf5xHzEfJRZwGLbQEWL5YZbeKjLOcq0tw6Dfkj-JYoTr7Kiym_vBJXa2Qpb9UbcP4stUM9qWl9P3789fQZAv4IGacGAnfrsZFpAuEvx3wsuFonm5CYJC7yCV8VFaRirWZprCDGIfHKrsj5_BCDNLVe1cUAgQ73T_6VkM5fk1c9kqTHneu3yFqotsmLSV8rf0N-HldNGR4g6uGr4Olpvbim31vVG3AFRZWIGvMWbWZwuvy9qANFUkpLuIhNOei3ruXqnOK_WnrWjjR_ekum52c_Ti6iXkUh8jxmTZS4kEuWu8IqpXySORGneZoLbUXslM6VSDTzcVwAMrLMKRuYcFYX0vEM4JdP35GNalaF94SywgOdchmAqgKIVWYdV5llSZ7K1PtUjQhbGs34vsU4Kl3cG6AaaGcDdjZoZxNLww3YeUQ-rR556Ppr_OvmQ_CEufOlwa7YeLyembvaAPb_YmBCgDaSEfmwdJSBUMH6h63CbDE3gGQ08OFM8BFRAw-uXo3DDq9U5U3bdFsJHmuV7vzPFHbJS5x3t-dvj2w09SLsA3Zp3EHL-Q_adfkHK8vs3Q |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiepileptic+Drug+Selection+According+to+Seizure+Type+in+Adult+Patients+with+Epilepsy&rft.jtitle=Journal+of+clinical+neurology+%28Seoul%2C+Korea%29&rft.au=%EA%B9%80%ED%98%9C%EC%9C%A4&rft.au=%EA%B9%80%EB%8F%99%EC%9A%B1&rft.au=%EC%9D%B4%EC%88%9C%ED%83%9C&rft.au=%EB%B3%80%EC%A0%95%EC%9D%B5&rft.date=2020-10-01&rft.pub=%EB%8C%80%ED%95%9C%EC%8B%A0%EA%B2%BD%EA%B3%BC%ED%95%99%ED%9A%8C&rft.issn=1738-6586&rft.eissn=2005-5013&rft.spage=547&rft.epage=555&rft_id=info:doi/10.3988%2Fjcn.2020.16.4.547&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_9582662 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1738-6586&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1738-6586&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1738-6586&client=summon |